Search Results - "Lok, A. S. F"

Refine Results
  1. 1

    IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection by Rao, H.-Y., Sun, D.-G., Jiang, D., Yang, R.-F., Guo, F., Wang, J.-H., Liu, F., Zhang, H.-Y., Zhang, H.-H., Du, S.-C., Jin, Q., Qin, H., Lok, A.-S.-F., Wei, L.

    Published in Journal of viral hepatitis (01-03-2012)
    “…Single nucleotide polymorphisms (SNPs) near the IL28B gene have been shown to be associated with response to treatment for chronic hepatitis C and also with…”
    Get full text
    Journal Article
  2. 2

    Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States by Wai, C.-T., Fontana, R. J., Polson, J., Hussain, M., Shakil, A. O., Han, S.-H., Davern, T. J., Lee, W. M., Lok, A. S.-F

    Published in Journal of viral hepatitis (01-03-2005)
    “…The role of hepatitis B virus (HBV) genotypes in the outcome of acute HBV infection is unclear. In this study, we aimed to evaluate the clinical and…”
    Get full text
    Journal Article
  3. 3

    Recipient Morbidity After Living and Deceased Donor Liver Transplantation: Findings from the A2ALL Retrospective Cohort Study by Freise, C. E., Gillespie, B. W., Koffron, A. J., Lok, A. S. F., Pruett, T. L., Emond, J. C., Fair, J. H., Fisher, R. A., Olthoff, K. M., Trotter, J. F., Ghobrial, R. M., Everhart, J. E.

    Published in American journal of transplantation (01-12-2008)
    “…Patients considering living donor liver transplantation (LDLT) need to know the risk and severity of complications compared to deceased donor liver…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort by Kulik, L. M., Fisher, R. A., Rodrigo, D. R., Brown, Jr, R. S., Freise, C. E., Shaked, A., Everhart, J. E., Everson, G. T., Hong, J. C., Hayashi, P. H., Berg, C. L., Lok, A. S. F.

    Published in American journal of transplantation (01-11-2012)
    “…Hepatocellular carcinoma (HCC) represents an increasing fraction of liver transplant indications; the role of living donor liver transplant (LDLT) remains…”
    Get full text
    Journal Article
  6. 6

    Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver Transplantation by Fisher, R. A., Kulik, L. M., Freise, C. E., Lok, A. S. F., Shearon, T. H., Brown, R. S., Ghobrial, R. M., Fair, J. H., Olthoff, K. M., Kam, I., Berg, C. L.

    Published in American journal of transplantation (01-06-2007)
    “…We examined mortality and recurrence of hepatocellular carcinoma (HCC) among 106 transplant candidates with cirrhosis and HCC who had a potential living donor…”
    Get full text
    Journal Article
  7. 7

    Dynamic prediction of risk of liver-related outcomes in chronic hepatitis C using routinely collected data by Konerman, M. A., Brown, M., Zheng, Y., Lok, A. S. F

    Published in Journal of viral hepatitis (01-06-2016)
    “…Summary Accuracy of risk assessments for clinical outcomes in patients with chronic liver disease has been limited given the nonlinear nature of disease…”
    Get full text
    Journal Article
  8. 8

    Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation by Degertekin, B., Han, Steven‐Huy B., Keeffe, E. B., Schiff, E. R., Luketic, V. A., Brown, Jr, R. S., Emre, S., Soldevila‐Pico, C., Reddy, K. R., Ishitani, M. B., Tran, T. T., Pruett, T. L., Lok, A. S. F.

    Published in American journal of transplantation (01-08-2010)
    “…The availability of hepatitis B immune globulin (HBIG) and several oral antiviral therapies has reduced but not eliminated hepatitis B virus (HBV) recurrence…”
    Get full text
    Journal Article
  9. 9

    Variation in Organ Quality between Liver Transplant Centers by Volk, M. L., Reichert, H. A., Lok, A. S. F., Hayward, R. A.

    Published in American journal of transplantation (01-05-2011)
    “…A wide spectrum of quality exists among deceased donor organs available for liver transplantation. It is unknown whether some transplant centers systematically…”
    Get full text
    Journal Article
  10. 10

    World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants by Funk, M. L., Rosenberg, D. M., Lok, A. S. F.

    Published in Journal of viral hepatitis (01-01-2002)
    “…Hepatitis B is a serious disease that is endemic in many parts of the world. A significant proportion of patients with chronic hepatitis B (CHB) are infected…”
    Get full text
    Journal Article
  11. 11

    Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs by Chotiyaputta, W., Hongthanakorn, C., Oberhelman, K., Fontana, R. J., Licari, T., Lok, A. S. F.

    Published in Journal of viral hepatitis (01-03-2012)
    “…Medication adherence is important for the success of nucleos(t)ide analogue (NUC) treatment for chronic hepatitis B. The aims of this study were to determine…”
    Get full text
    Journal Article
  12. 12

    Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B by Fung, S. K., Wong, F., Hussain, M., Lok, A. S. F.

    Published in Journal of viral hepatitis (01-09-2004)
    “…Lamivudine has demonstrated efficacy for the treatment of hepatitis B e antigen‐negative chronic hepatitis B (e‐CHB). However, treatment withdrawal after 1…”
    Get full text
    Journal Article
  13. 13

    Endpoints of hepatitis B treatment by Chotiyaputta, W., Lok, A. S. F.

    Published in Journal of viral hepatitis (01-10-2010)
    “…The goal of hepatitis B treatment is to prevent the development of cirrhosis, liver failure, and hepatocellular carcinoma. Ideally, clinical studies should…”
    Get full text
    Journal Article
  14. 14

    Seroepidemiological survey of hepatitis E in Hong Kong by recombinant-based enzyme immunoassays by Lok, A S, Kwan, W K, Moeckli, R, Yarbough, P O, Chan, R T, Reyes, G R, Lai, C L, Chung, H T, Lai, T S

    Published in The Lancet (British edition) (14-11-1992)
    “…The agent that causes the enterally transmitted form of non-A, non-B hepatitis has been cloned and called hepatitis E virus (HEV). We have carried out a…”
    Get more information
    Journal Article
  15. 15

    Hepatitis B: Liver fibrosis and hepatocellular carcinoma by Lok, A.S.F.

    Published in Gastroentérologie clinique et biologique (01-10-2009)
    “…Chronic hepatitis B virus (HBV) infection is estimated to be the cause of 55–60% of hepatocellular carcinoma (HCC) in the world. It has been estimated that up…”
    Get full text
    Journal Article
  16. 16

    Characteristics of chronic hepatitis B patients who underwent liver biopsies by Chotiyaputta, W., Degertekin, B., McKenna, B. J., Samala, N., Fontana, R. J., Lok, A. S. F.

    Published in Journal of viral hepatitis (01-11-2011)
    “…Significant liver disease has been reported in chronic hepatitis B patients with normal alanine aminotransferase (ALT) but most studies performed biopsies on…”
    Get full text
    Journal Article
  17. 17

    Management of hepatitis C patients by primary care physicians in the USA: results of a national survey by Shehab, T. M., Sonnad, S. S., Lok, A. S. F.

    Published in Journal of viral hepatitis (01-09-2001)
    “…Hepatitis C is a major health problem worldwide, yet very little research has been performed to assess the knowledge base and practice patterns of primary care…”
    Get full text
    Journal Article
  18. 18

    High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection by Bozkaya, H, Ayola, B, Lok, A S F

    Published in Hepatology (Baltimore, Md.) (01-07-1996)
    “…Cross‐sectional studies reported that hepatitis B core gene mutations are associated with active liver disease and responsiveness to interferon therapy. In…”
    Get full text
    Journal Article
  19. 19

    Diagnosis of hepatitis C by Lok, A S, Gunaratnam, N T

    Published in Hepatology (Baltimore, Md.) (01-09-1997)
    “…Currently, the second‐ and third‐generation enzyme immunoassays (EIA‐2 and EIA‐3) for hepatitis C virus antibody (anti‐HCV) are the most practical screening…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs by GHANY, M. G, LEISSINGER, C, LAGIER, R, SANCHEZ-PESCADOR, R, LOK, A. S. F

    Published in Digestive diseases and sciences (01-06-1996)
    “…Chronic liver disease due to hepatitis C virus (HCV) infection is a major problem in hemophiliacs. Recent reports suggested that hemophiliacs coinfected with…”
    Get full text
    Journal Article